Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indomobil Sukses Internasional Tbk. (IMAS) vs Merck Tbk. (MERK) Price & Performance

Indomobil Sukses Internasional Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Indomobil Sukses Internasional Tbk. vs Merck Tbk. — how do they compare? Indomobil Sukses Internasional Tbk. trades at Rp860 (market cap 3.34T, 89.9K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Indomobil Sukses Internasional Tbk. is the larger of the two by market cap, and Indomobil Sukses Internasional Tbk. is more actively traded (89.9K versus 21.9K). Which is the better fit depends on your goals.

IMASMERK
Market Cap
3.34T1.7T
Volume
89.9K21.9K
Lot
899219
Turnover
75.57M83.99M
Average Price
840.633,834.93
Value
75.57M83.99M
Indicative Equilibrium Price
8353,850
Indicative Equilibrium Volume
4001

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IMAS
View details
MERK
View details

About Indomobil Sukses Internasional Tbk.

PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.

Read more on IMAS

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK